Key result
M712T founder mutation demonstrates incomplete penetrance and wider phenotypic spectrum in hereditary inclusion body myopathy.
Why the study?
The phenotypic spectrum and epidemiology of hereditary inclusion body myopathy (HIBM) in Middle Eastern populations beyond Persian Jews were not fully characterized.
Observational (n=134)
Answers are grounded in this paper and cite their sources.
The M712T mutation causing hereditary inclusion body myopathy is a founder mutation in the Middle East with incomplete penetrance and a wider phenotypic spectrum than previously recognized.
BACKGROUND: Recessively inherited hereditary inclusion body myopathy (HIBM) with quadriceps sparing was initially described only in Jews originating from the region of Persia. The recent identification of the gene responsible for this myopathy and the common "Persian Jewish mutation" (M712T) enabled the re-evaluation of atypical phenotypes and the epidemiology of HIBM in various communities in the Middle East. OBJECTIVE: To test for the M712T mutation in the DNA from HIBM patients in the Middle East. METHODS: DNA from all suspected HIBM patients was tested for the M712T mutation. Unaffected members of families with genetically proven HIBM were studied too. In the majority of families, haplotype construction with markers spanning the 700-kb region of the HIBM gene was performed. RESULTS: One hundred twenty-nine HIBM patients of 55 families (Middle Eastern Jews, Karaites, and Arab Muslims of Palestinian and Bedouin origin) were homozygous for the M712T mutation, and all carried the same haplotype. Five clinically unaffected subjects were also homozygous for the common mutation and haplotype, including two older adults (ages 50 and 68 years). Atypical features with this same mutation were marked quadriceps weakness in five patients, proximal weakness only in two patients, facial weakness in three patients, and a muscle biopsy showing perivascular inflammation in one patient. CONCLUSIONS: The phenotypic spectrum of recessive HIBM is wider than previously described, and the diagnostic criteria for this myopathy must be changed. The Middle Eastern cluster is the result of a founder mutation, with incomplete penetrance, that is approximately 1,300 years old and is not limited to Jews.
No takes yet. Share an insight, caveat, or question.
Argov et al. (2003) conducted an observational in Hereditary inclusion body myopathy (HIBM) (n=134). M712T mutation was evaluated on Homozygosity for the M712T mutation and haplotype. The M712T founder mutation was identified in 129 Middle Eastern patients with hereditary inclusion body myopathy, demonstrating a wider phenotypic spectrum and incomplete penetrance.
Synapse has enriched 10 related papers. Consider them for comparative context: